Tumor-associated cysteine proteinase activities in human melanoma cells and fibroblasts of different origin

European Journal of Cell Biology

Volumn 73, Issue 4, 1997, Pages 344-351

  Mayer, Patricia ^a   Schmid, Heide ^a,b   Schaber, Bernd ^a   Fierlbeck, Gerhard ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Cathepsin B; Fibroblasts; Melanoma cell lines; Tumor associated cathepsin B

Indexed keywords

CATHEPSIN B; CATHEPSIN L; COUMARIN DERIVATIVE; CYSTEINE PROTEINASE; UREA;

ARTICLE; CELL SUBPOPULATION; ENZYME INACTIVATION; FIBROBLAST; FLUOROMETRY; HUMAN; HUMAN CELL; MELANOMA CELL; MICHAELIS CONSTANT; PH; PRIORITY JOURNAL;

EID: 0030799395     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Baici, A., M. Knöpfel: Cysteinc proteinase produced by cultured rabbit V2 carcinoma cells and rabbit skin fibroblasts. Int. J. Cancer 38, 753-759 (1986).
2. Baricos, W. H., Y. Zhou, R. W. Mason, A. J. Barrett: Human kidney cathcpsins B and L. Characterization and potential role in degradation of glomcrular basement membrane. Biochem. J. 252, 301-304 (1988).
3. Barrett, A. J., H. Kirschke: Cathepsin B, cathepsin H and cathepsin L. Methods Enzymol. 80, 535-561 (1981).
4. Barrett, A. J., A. A. Kembhavi, M. A. Brown, H. Kirschke, C. G. Knight, M. Tamai, K. Hanada: L-trans-Epoxysuccinyl-leucylamido (4-guanidino) butane (E-64) and its analogues as inhibitors of cysteine proteinases including eathepsins B, H and L. Biochem. J. 201, 189-198 (1982).
5. Bassalyk, L. S., P. E. Tsanev, S. M. Parshikova, L. V. Demidov: Lysosomal proteolytic enzymes in the process of melanoma invasion and metastasis. Voprosy Onkologii (Leningrad) 38, 418-425 (1992).
6. Bauer, E. A., J. L. Seltzer, A. Z. Eisen: Retinoic acid inhibition of collagenase and gelatinase expression in human skin fibroblast cultures. Evidence for a dual mechanism. J. Invest. Dermatol. 81, 162-169 (1983).
7. Bohley, P., P. O. Seglen: Proteases and proteolysis in the lysosome. Experientia 48, 151-157 (1992).
8. Bond, J. S., P. E. Butler: Intracellular proteases. Annu. Rev. Biochem. 56, 333-364 (1987).
9. Bröcker, E.-B., E. Macher, C. Sorg: Changes in the tumor-associated inflammatory infiltrates in the course of local and systemic progression of cutaneous melanoma. In: S. Ferrone: Human Melanoma. From Basic Research to Clinical Application, pp. 279-293. Springer Verlag. Berlin, Heidelberg, New York 1990.
10. Brömme, D., A. Steinert, S. Friebe, S. Fittkau, B. Wiederanders, H. Kirschke: The specificity of bovine spleen cathepsin S. A comparison with rat liver cathepsin L and B. Biochem. J. 264, 475-481 (1989).
11. Buck, M. R., D. G. Karustis, N. A. Day, K. V. Honn, B. F. Sloane: Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. Biochem. J. 282, 273-278 (1992).
12. Cardozo, C., C. Kurtz, M. Lesser: Degradation of rat lung collagens by cathepsin B. J. Lab. Clin. Med. 119, 169-175 (1992).
13. Chambers, A. F., R. Colella, D. T. Denhardt, S. M. Wilson: Increased expression of cathepsin L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells. Mol. Carcinog. 5, 238-245 (1992).
14. Chauhan, S. S., L. J. Goldstein, M. M. Gottesman: Expression of cathepsin L in human tumors. Cancer Res. 41, 1478-1481 (1991).
15. Dahlmann, B., L. Kuehn, M. Rutschmann, H. Reinauer: Purification and characterization of a multicatalytic high-molecular-mass proteinase from rat skeletal muscle. Biochem. J. 228, 161-170 (1985).
16. Dengler, R., T. Lah, D. Gabrijelcic, V. Turk, H. Fritz, B. Emmerich: Detection of cathepsin B in tumour cytosol and urine of breast cancer patients. Biomed. Biochim. Acta 50, 555-560 (1991).
17. Dodwell, D. J.: Proteinase inhibitors in malignancy: therapeutic promise or another white elephant? J. Royal Soc. Med. 86, 573-576 (1993).
18. Donatien, P. D., S. L. Diment, R. E. Boissy, S. J. Orlow: Melanosomal and lysosomal alterations in murine melanocytcs following transfection with the v-rasHa oncogene. Int. J. Cancer 66, 557-563 (1996).
19. Edward, M., R. M. Mackie: Cell-cell and cell-extracellular matrix interactions during melanoma cell invasion and metastasis. Melanoma Res. 3, 227-234 (1993).
20. Emmert-Buck, M. R., M. J. Roth, Z. Zhuang, E. Campo, J. Rozhin, B. F. Sloane, L. A. Liotta, W. G. Stetler-Stevenson: Increased gelatinase A (MMP-2) and cathepsin B activity in invasive regions of human colon cancer samples. Am. J. Pathol. 145, 1285-1290 (1994).
21. Fröhlich, E., G. Schaumburg-Lever, C. Klessen: Immunocytochemical and immunoelectron microscopic demonstration of cathepsin B in human malignant melanoma. Br. J. Dermatol. 132, 867-875 (1995).
22. Gabrijelcic, D., B. Svetic, D. Spaic, J. Skrk, M. Budihna, I. Dolenc, T. Popovic, V. Cotic, V. Turk: Cathepsins B, H and L in human breast carcinoma. Eur. J. Clin. Chem. Clin. Biochem. 30, 69-74 (1992).
23. Goslen, J. B., A. Z. Eisen, E. A. Bauer: Stimulation of skin fibroblast collagenase production by a cytokine derived from basal cell carcinomas. J. Invest. Dermatol. 85, 161-164 (1985).
24. Khan, M. Y., S. K. Agarwal, S. Ahmad: Structure-activity reltionship in buffalo spleen cathepsin B. J. Biochem. 111, 732-735 (1992).
25. Kirschke, H., I. Schmidt, B. Wiederanders: Cathepsin S: the cysteine proteinase from bovine lymphoid tissue is distinct from cathepsin L (EC 3.4.22.15). Biochem. J. 240, 455-459 (1986).
26. Kirschke, H., B. Wiederanders, D. Brömme, A. Rinne: Cathepsin S from bovine spleen. Purification, distribution, intracellular localization and actions on proteins. Biochem. J. 264, 467-473 (1989).
27. Kobayashi, H., H. Moniwa, M. Sugumua: Effects of membrane associated cathepsin B on the activation of receptor-bound urokinase and subsequent invasion of reconstituted basement membranes. Biochim. Biophys. Acta 1178, 55-62 (1993).
28. Kominami, E., T. Tsukahara, Y. Bando, N. Katunuma: Distribution of cathepsin B and H in rat tissues and peripheral blood cells. J. Biochem. 98, 87-93 (1985).
29. Lah, T. T., J. L. Clifford, K. M. Helmer, N. A. Day, K. Moin, K. V. Honn, J. D. Crissman, B. F. Sloane: Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma. Biochim. Biophys. Acta 993, 63-73 (1989).
30. Lah, T. T., M. Kokalj-Kunovar, M. Drobnic-Kosorok, J. Babnik, R. Golouh, I. Vrhovec, V. Turk: Cystatins and cathepsins in breast carcinoma. Biol. Chem. Hoppe-Seyler 373, 595-604 (1992).
31. Liotta, L. A.: Editorial. Cancer Metastasis Rev. 9, 285-287 (1990).
32. Maciewicz, R. A., R. J. Wardale, D. J. Etherington, C. Paraskeva: Immunodetection of cathepsin B and L present in and secreted from human pre-malignant and malignant colorectal tumour cell lines. Int. J. Cancer 43, 478-485 (1989).
33. Mareel, M. M., P. De Baetselier, F. M. Van Roy: Hydrolase activities as elements of malignancy. In: M. M. Mareel, P. De Baetselier, F. Van Roy (eds.): Mechanisms of Invasion and Metastasis. pp. 127-128. CRC Press. Ann Arbor, Boston 1991.
34. Mignatti, P., D. B. Rifkin: Biology and biochemistry of proteinases in tumour invasion. Physiol. Rev. 73, 161-195 (1993).
35. Moin, K., J. Rozhin, T. B. McKernan, V. J. Sanders, D. Fong, K. V. Honn, B. F. Sloane: Enhanced levels of cathepsin B mRNA in murine tumours. FEBS Lett. 244, 61-64 (1989).
36. Moin, K., N. A. Day, M. Sameni, S. Hasnain, T. Hirama, B. F. Sloane: Human tumour cathepsin B. Biochem. J. 285, 427-434 (1992).
37. Olbricht, C. J., J. K. Cannon, L. C. Garg, C. C. Tisher: Activities of cathepsin B and L in isolated nephron segments from proteinuric and non proteinuric rats. Am. J. Physiol. 250, F1055-F1062 (1986).
38. Redwood, S. M., B. C.-S. Liu, R. E. Weiss, D. E. Hodge, M. J. Droller: Abrogation of the invasion of human bladder tumor cells by using protease inhibitor(s). Cancer 69, 1212-1219 (1992).
39. Rozhin, J., R. L. Wade, K. V. Honn, B. F. Sloane: Membrane-associated cathepsin L: A role in metastasis of melanoma. Biochem. Biophys. Res. Commun. 164, 556-561 (1989).
40. Rozhin, J., A. P. Gomez, G. H. Ziegler, K. K. Nelson, Y. S. Chang, D. Fong, J. M. Onoda, K. V. Honn, B. F. Sloane: Cathepsin B to cysteine proteinase inhibitor balance in metastatic cell subpopulations isolated from murine tumors. Cancer Res. 50, 6278-6284 (1990).
41. Ruoslahti, E.: Control of cell motility and tumour invasion by extracellular matrix interactions. Br. J. Cancer 66, 239-244 (1992).
42. Schaber, B.: Einfluß von natürlichem Interferon alpha, 13 cis Retinsäure und ihrer Kombination auf das Wachstum, die Antigenexpression und das invasive Potential bei Melanomzellen in vitro. PhD Thesis, Faculty of Biology, University of Tübingen (1996).
43. Schmid, H., M. Koop, S. Utermann, L. Lambacher, P. Mayer, L. Schaefer: Specific catalytic activity of cathepsin S in comparison to cathepsins B and L along the rat nephron. Biol. Chem. 378, 61-69 (1997).
44. Shuja, S., K. Sheahan, M. J. Murnane: Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas. Int. J. Cancer 49, 341-346 (1991).
45. Sinha, A. A., D. F. Gleason, O. F. DeLeon, M. J. Wilson, B. F. Sloane: Localization of biotinylated cathepsin B oligonucleotide probe in human prostate including invasive cells and invasive edges by in situ hybridization. Anat. Rec. 235, 233-240 (1993).
46. Sloane, B. F., J. Rozhin, K. Johnson, H. Taylor, J. D. Crissman, K. V. Honn: Cathepsin B: Association with plasma membrane in metastatic tumors. Proc. Natl. Acad. Sci. USA 83, 2483-2487 (1986).
47. Sloane, B. F., J. Rozhin, J. S. Hatfield, J. D. Crissman, K. V. Honn: Plasma membrane-associated cysteine proteinases in human and animal tumors. Exp. Cell Biol. 55, 209-224 (1987).
48. Sloane, B. F.: Cathepsin B and cystatins: evidence for a role in cancer progression. Seminars Cancer Biol. 1, 137-152 (1990).
49. Sloane, B. F., K. Moin, E. Krepela, J. Rozhin: Cathepsin B and its endogenous inhibitors: the role in tumour malignancy. Cancer Metastasis Rev. 9, 333-352 (1990).
50. Solovyeva, N. I., T. O. Balayevskaya, E. A. Dilakyan, T. A. Zakamaldina-Zama, V. F. Pozdnev, L. Z. Topol: Proteolytic enzymes at various stages of oncogenic transformation of rat fibroblasts. I. Aspartyl and cysteine proteinases. Int. J. Cancer 60, 495-500 (1995).
51. Spiess, E., A. Brüning, S. Gack, B. Ulhricht, H. Spring, G. Trefz, W. Ebert: Cathepsin B activity in human lung tumor cell lines: Ultrastructural localization, pH sensitivity, and inhibitor status at the cellular level. J. Histochem. Cytochem. 42, 917-929 (1994).
52. Stetler-Stevenson, W. G., S. Aznavoorian, L. A. Liotta: Tumour cell interactions with extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9, 541-573 (1993).
53. Tomita, K., H. Endou, F. Sakai: Localization of kallikrein-like activity along a single nephron in rabbits. Pflügers Arch. 389, 91-95 (1981).
54. Welch, D. R., J. E. Bisi, B. E. Miller, D. Conaway, E. A. Seftor, K. H. Yohem, L. B. Gilmore, R. E. B. Seftor, M. Nakajima, M. J. C. Hendrix: Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line. Int. J. Cancer 47, 227-237 (1991).
55. Werle, B., W. Ebert, W. Klein, E. Spiess: Assessment of cathepsin L activity by use of the inhibitor CA-074 compared to cathepsin B activity in human lung tumour tissue. Biol. Chem. Hoppe-Seyler 376, 157-164 (1995).
56. Young, P. R., S. M. Spevacek: Substratum acidification and proteinase activation by murine B16 melanoma cultures. Biochim. Biophys. Acta 1182, 69-74 (1993).
57. Zucker, S.: A critical appraisal of the role of proteolytic enzymes in cancer invasion: emphasis on tumour surface proteinases. Cancer Invest. 6, 219-231 (1988).